...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM Sept. 12, 2018
3
Jun 29, 2018 04:45PM

I wonder if there is any particular reason they moved the AGM to Sept from Dec.

tada

4
Jun 29, 2018 11:58PM
3
Jun 30, 2018 10:09AM
5
Jun 30, 2018 10:59AM
Share
New Message
Please login to post a reply